An Active Health-Based Comprehensive Study on Diabetes Management
Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This randomized, open-label, multicenter trial evaluates the efficacy and safety of the AI-based lifestyle guidance system (X Life) compared to standard care in adults with type 2 diabetes. X Life integrates CGM, wearable devices, and AI-driven decision models to provide personalized lifestyle recommendations. The primary endpoint is the percentage of time in glucose target range (TIR).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 70
Healthy Volunteers: f
View:
• Age 18-70 years
• Diagnosed type 2 diabetes
• Stable medication regimen ≥ 3 months
• HbA1c 7-10%
• Smartphone access and ability to operate app
• Willing to wear CGM and activity tracker
• Able to provide informed consent
Locations
Other Locations
China
Shanghai Sixth People's Hospital
RECRUITING
Shanghai
Time Frame
Start Date: 2025-09-07
Estimated Completion Date: 2025-10-26
Participants
Target number of participants: 124
Treatments
Experimental: X Life AI Lifestyle Guidance
Personalized real-time lifestyle recommendations delivered via smartphone/tablet, integrating CGM and wearable data.
Active_comparator: Standard Care
Participants receive standard diabetes management including medications and lifestyle recommendations based on guidelines.
Related Therapeutic Areas
Sponsors
Leads: Li Huating